Two-field Versus Three-field Lymphadenectomy in Thoracic Esophageal Carcinoma Without Cervical Lymph Node Involvement

NCT02448953 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 786

Last updated 2015-05-20

No results posted yet for this study

Summary

The purpose of this study is to compare the lymph node dissection results and prognosis in thoracic esophageal carcinoma patients without cervical lymph node involvement by preoperative CT and/or ultrasound treated by two-field lymphadenectomy or three-field lymphadenectomy.Another purpose of this study is to clarify whether the lymph node along the right recurrent laryngeal nerve can be taken as the sentinel lymph node which is able to indicate neck lymph node metastasis and necessity for three-field lymphadenectomy.

Conditions

  • Esophageal Cancer

Interventions

PROCEDURE

Two-field lymphadenectomy

Thoracic-upper abdominal two-field lymphadenectomy

PROCEDURE

Three-field lymphadenectomy

Cervical-thoracic-upper abdominal three-field completely lymphadenectomy

Sponsors & Collaborators

  • Peking University Cancer Hospital & Institute

    collaborator OTHER
  • Henan Cancer Hospital

    collaborator OTHER_GOV
  • Hebei Medical University Fourth Hospital

    collaborator OTHER
  • Sichuan Cancer Hospital and Research Institute

    collaborator OTHER
  • Fujian Cancer Hospital

    collaborator OTHER_GOV
  • Liaoning Cancer Hospital & Institute

    collaborator OTHER
  • Zhejiang Cancer Hospital

    collaborator OTHER
  • Tongji Hospital

    collaborator OTHER
  • Tang-Du Hospital

    collaborator OTHER
  • Shanghai Chest Hospital

    collaborator OTHER
  • Chinese Academy of Medical Sciences

    lead OTHER

Principal Investigators

  • Jie He, MD,PhD · Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2017-09-30
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02448953 on ClinicalTrials.gov